Lunch and Learn
“A novel mRNA vaccine platform for HIV-1”
Presented by: Dr Paolo Lusso, M.D., Ph.D.
Chief, Viral Pathogenesis Section in the Laboratory of Immunoregulation
When: Friday April 14th, 12:00pm-1:30pm
Where: George Mason University SciTech Campus (Manassas, VA), Kathryn Johnson Hall, RM 130 (in-person only)
Register to Attend for Free: https://ibi.gmu.edu/event/
Complimentary lunch with registration
Dr. Lusso received his M.D., summa cum laude, from the University of Turin and his Ph.D. from the Ministry of Scientific and Technologic Research, Rome, Italy. He is a board-certified specialist in internal medicine and in infectious diseases. He came to NIH for the first time in 1986 to work in the Laboratory of Tumor Cell Biology under Dr. Robert C. Gallo at the National Cancer Institute. He returned to Italy in 1994, where he created the Laboratory of Human Virology at the San Raffaele Scientific Institute in Milan and became associate professor of infectious diseases at the University of Cagliari. In 2006, he again joined NIH, where he became chief of the Viral Pathogenesis Section in the Laboratory of Immunoregulation. He is an executive editor of Current HIV Research and a member of the editorial board of several other journals. He is an elected member or the European Molecular Biology Organization (EMBO) and a Fellow of the American Academy of Microbiology (AAM).
Dr. Lusso’s major areas of research include:
- Novel approaches (including mRNA) to the development of an HIV-1 vaccine
- Structure-function relationships in the HIV-1 envelope
- Structure-based design of improved therapeutic monoclonal antibodies
- Molecular basis of HIV-1 immune evasion
- Role of chemokines and other endogenous immune modulators in HIV-1 disease
Sponsored by: Virginia Bio-Connect, GO Virginia
Hosted by: George Mason University’s Center for Infectious Disease Research and Northern Virginia BioHub